Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.30 |
| ▸ | LTK | P29376 | 1/20 | 0.30 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.30 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.30 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24188606 | 0.78 | KDM1A (0.41) | KDM1A | |
| SCHEMBL4423059 | 0.77 | KDM1A (0.35) | CYP2A6KDM1ANTRK1LTKTYRO3 | |
| SCHEMBL4417235 | 0.77 | NTRK1 (0.39) | CYP2A6KDM1ANTRK1LTKTYRO3 | |
| SCHEMBL24188612 | 0.74 | KDM1A (0.41) | KDM1ANTRK1LTKTYRO3NTRK2 | |
| SCHEMBL24188494 | 0.74 | KDM4E (0.42) | GLAGAA | |
| SCHEMBL24188520 | 0.70 | KDM4E (0.35) | GLA | |
| SCHEMBL17010921 | 0.68 | CYP2A6 (0.36) | CYP2A6KDM1ANTRK1LTKTYRO3 | |
| SCHEMBL13403290 | 0.67 | GAA (0.39) | CYP2A6GLAGAAL3MBTL1 | |
| SCHEMBL1041559 | 0.67 | CYP2A6 (0.48) | CYP2A6 | |
| SCHEMBL20618778 | 0.67 | KCNH2 (0.41) | GAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220013735-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220013735-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OXA1L, ICOSLG, ODC1 | CYP2A6 3124/4885KDM1A 2675/4885NTRK1 1798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.